COSCIENS Biopharma Inc. (TSX:CSCI)

Market Cap	9.30M +34.3%
Revenue (ttm)	12.61M -4.0%
Net Income	-20.76M
EPS	-6.58
Shares Out	3.18M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	302
Average Volume	1,399
Open	2.750
Previous Close	2.740
Day's Range	2.750 - 2.920
52-Week Range	2.740 - 6.460
Beta	1.31
RSI	51.73
Earnings Date	Mar 25, 2026

About COSCIENS Biopharma

COSCIENS Biopharma Inc., a life science company, develops and commercializes products for the cosmeceutical, nutraceutical and pharmaceutical markets in the United States, Germany, Colombia, the United Kingdom, and internationally. It operates through Active Ingredient and Pharmaceutical segments. The company offers active ingredients comprising oat beta glucan, a chewable for cholesterol reduction; beta glucan from yeast, a nutraceutical-capsule used as an immune booster; and avenanthramides, a nutraceutical-chewable formulation used to reduce...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1990
• Employees: 40
• Stock Exchange: Toronto Stock Exchange
• Ticker Symbol: CSCI

Financial Performance

In 2024, COSCIENS Biopharma's revenue was $9.59 million, an increase of 34.22% compared to the previous year's $7.14 million. Losses were -$15.31 million, 339.3% more than in 2023.

Financial numbers in USD